Mostrar el registro sencillo del ítem

dc.contributor.authorCano Cortes, María Victoria 
dc.contributor.authorAltea-Manzano, Patricia
dc.contributor.authorLaz Ruiz, José Antonio
dc.contributor.authorUnciti Broceta, Juan Diego
dc.contributor.authorLópez Delgado, Francisco Javier
dc.contributor.authorEspejo Román, José Manuel 
dc.contributor.authorDíaz Mochón, Juan José 
dc.contributor.authorSánchez Martín, Rosario María 
dc.date.accessioned2021-03-19T11:42:42Z
dc.date.available2021-03-19T11:42:42Z
dc.date.issued2021-02-14
dc.identifier.citationCano-Cortes, M. V., Altea-Manzano, P., Laz-Ruiz, J. A., Unciti-Broceta, J. D., Lopez-Delgado, F. J., Espejo-Roman, J. M., ... & Sanchez-Martin, R. M. (2021). An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems. Nanoscale, 13(6), 3500-3511. [DOI: 10.1039/d0nr07145e]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/67345
dc.description.abstractIn this manuscript, we report the development of a versatile, robust, and stable targeting nanocarrier for active delivery. This nanocarrier is based on bifunctionalized polymeric nanoparticles conjugated to a monoclonal antibody that allows for active targeting of either (i) a fluorophore for tracking or (ii) a drug for monitoring specific cell responses. This nanodevice can efficiently discriminate between cells in coculture based on the expression levels of cell surface receptors. As a proof of concept, we have demonstrated efficient delivery using a broadly established cell surface receptor as the target, the epidermal growth factor receptor (EGFR), which is overexpressed in several types of cancers. Additionally, a second validation of this nanodevice was successfully carried out using another cell surface receptor as the target, the cluster of differentiation 147 (CD147). Our results suggest that this versatile nanocarrier can be expanded to other cell receptors and bioactive cargoes, offering remarkable discrimination efficiency between cells with different expression levels of a specific marker. This work supports the ability of nanoplatforms to boost and improve the progress towards personalized medicine.es_ES
dc.description.sponsorshipHealth Institute Carlos III (ISCIII) DTS18/00121es_ES
dc.description.sponsorshipJunta de Andalucia-FEDER, Ministry of Economy, Knowledge, Companies and University (University of Granada) B-FQM-475-UGR18 PT18-TP-1490 AT17_6096- OTRIes_ES
dc.description.sponsorshipSpanish State Research Agency RED2018-102469-Tes_ES
dc.description.sponsorshipFundación Benéfica Anticáncer San Francisco Javier y Santa Cándidaes_ES
dc.description.sponsorshipSpanish Ministry of Economy and Competitiveness PTQ-16- 08597es_ES
dc.description.sponsorshipSpanish Government FPU 16/02061es_ES
dc.language.isoenges_ES
dc.publisherRoyal Society Chemistryes_ES
dc.rightsAtribución-NoComercial 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.titleAn effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systemses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1039/d0nr07145e
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 3.0 España